Vattenfall Sells Kriegers Flak Offshore Wind Energy to Healthcare Company

Wind Industry Profile of

Production of insulin and enzymes is to be based on renewable energy from Denmark’s largest offshore wind farm, Kriegers Flak in the Baltic Sea. This is the result of a new long-term deal between global healthcare company Novo Nordisk, bio innovator Novozymes and the energy company Vattenfall.

Novo Nordisk and Novozymes will source their power consumption from Vattenfall and its offshore wind farm Kriegers Flak, which is being developed in the Baltic Sea. The deal will cover approximately a fifth of the farm’s production. Kriegers Flak is scheduled to be in full operation by the end of 2021. The deal enters into force from January 1 2020. Between then and 2021 the power will be sourced from other Vattenfall wind farms in Denmark. “Vattenfall is... ... More: Official Press Release Vattenfall

Keywords:

Vattenfall, Novo Nordisk, Novozymes, offshore, Kriegers Flak, insulin, enzyme, wind energy, power consumption